Nuclear factor-κB contributes to interleukin-4- and interferon-dependent polymeric immunoglobulin receptor expression in human intestinal epithelial cells

Immunology

Volumn 111, Issue 1, 2004, Pages 75-85

  Ackermann, Laynez W ^a   Denning, Gerene M ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 4; SECRETORY COMPONENT; TRANSCRIPTION FACTOR; ANTIINFECTIVE AGENT; ANTIOXIDANT; BAY 11 7085; BAY 11-7085; CARBOBENZOXY LEUCYL LEUCYL NORVALINAL; CARBOBENZOXY-LEUCYL-LEUCYL-NORVALINAL; DNA BINDING PROTEIN; ENZYME INHIBITOR; GAMMA INTERFERON; IRF1 PROTEIN, HUMAN; LEUPEPTIN; NITRILE; PHOSPHOPROTEIN; SODIUM SELENITE; SULFONE;

ANTIBODY PRODUCTION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENHANCER REGION; GENE CONSTRUCT; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTESTINE EPITHELIUM CELL; MUCOSAL IMMUNITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; TRANSCYTOSIS; CELL STRAIN HT29; DRUG ANTAGONISM; EPITHELIUM CELL; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; METHODOLOGY; NORTHERN BLOTTING; WESTERN BLOTTING;

ANTI-INFECTIVE AGENTS; ANTIOXIDANTS; BLOTTING, NORTHERN; BLOTTING, WESTERN; DNA-BINDING PROTEINS; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION; GENES, REPORTER; HT29 CELLS; HUMANS; IMMUNITY, MUCOSAL; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; INTERLEUKIN-4; INTESTINAL MUCOSA; LEUPEPTINS; NF-KAPPA B; NITRILES; PHOSPHOPROTEINS; RECEPTORS, POLYMERIC IMMUNOGLOBULIN; SODIUM SELENITE; SULFONES; TRANSFECTION;

EID: 0345865182     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.01773.x     Document Type: Article

References (40)

1. Kaetzel CS, Robinson JK, Chintalacharuvu KR, Vaerman JP, Lamm ME. The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA. Proc Natl Acad Sci U S A 1991; 88 (19):8796-800.
2. Mostov KE, Blobel G. Biosynthesis, processing, and function of secretory component. Methods Enzymol 1983; 98:458-66.
3. 2: a possible implication for mucosal defense. J Immunol 1998; 161:5445-53.
4. Marshall L, Perks B, Ferkol T, Shute J. IL-8 released constitutively by primary bronchial epithelial cells in culture forms an inactive complex with secretory component. J Immunol 2001; 167:2816-23.
5. McGee D, Aicher W, Eldridge J. Transforming growth factor-β enhances secretory component and major histocompatibility complex class I. Cytokine 1991; 3:543-50.
6. Kavale D, Lovhaug D, Sollid L, Brandtzaeg P. Tumor necrosis factor-α up-regulates expression of secretory component, the epithelial receptor for polymeric Ig. J Immunol 1988; 140:3086-9.
7. Hayashi M, Takenouchi N, Asano M, Kato M, Tsurumachi T, Saito T, Moro I. The polymeric immunoglobulin receptor (secretory component) in human intestinal epithelial cell lines is up-regulated by interleukin-1. Immunology 1997; 92:220-5.
8. Sollid LM, Kvale D, Brandtzaeg P, Markussen G, Thorsby E. Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol 1987; 138 (12):4303-6.
9. Denning G. IL-4 and IFN-γ synergistically increase total polymeric IgA receptor levels in human intestinal epithelial cells. J Immunol 1996; 156:4807-14.
10. Phillips JO, Everson MP, Moldoveanu Z, Lue C, Mestecky J. Synergistic effect of IL-4 and IFN-gamma on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J Immunol 1990; 145 (6): 1740-4.
11. Loman S, Jansen H, Out T, Lutter R. Interleukin-4 and interferon-γ synergistically increase secretory component gene expression, but are additive in stimulating secretory immunoglobulin A release by Calu-3 airway epithelial cells. Immunology 1999; 96:537-43.
12. Sarkar J, Gangopadhyay N, Moldoveanu Z, Mestecky J, Stephensen C. Vitamin A is required for regulation of polymeric immunoglobulin receptor (pIgR) expression by interleukin-4 and interferon-γ in a human intestinal epithelial cell line. J Nutr 1998; 128:1063-9.
13. Verrijdt G, Schoenmakers E, Alen P, Haelens A, Peeters B, Rombauts W, Claessens F. Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element. Mol Endocrinol 1999; 13:1558-70.
14. Ackermann L, Wollenweber L, Denning G. IL-4 and IFN-γ increase steady state levels of polymeric Ig receptor mRNA in human airway and intestinal epithelial cells. J Immunol 1999; 162:5112-8.
15. Nilsen E, Johansen F-E, Kvale D, Krajci P, Brandtzaeg P. Different regulatory pathways employed in cytokine-enhanced expression of secretory component and epithelial HLA class I genes. Eur J Immunol 1999; 29:168-79.
16. Piskurich JF, France JA, Tamer CM, Willmer CA, Kaetzel CS, Kaetzel DM. Interferon-γ induces polymeric immunoglobulin receptor mRNA in human intestinal epithelial cells by a protein synthesis dependent mechanism. Mol Immunol 1993; 30:413-21.
17. Takenouchi-Ohkubo N, Takahashi T, Tsuchiya M, Mestecky J, Moldoveanu Z, Moro I. Role of nuclear factor-κB in the expression by tumor necrosis factor-α of the human polymeric immunoglobulin receptor (plgR) gene. Immunogenetics 1999; 51:289-95.
18. Piskurich J, Youngman K, Phillips K, Hempen P, Blanchard M, France J, Kaetzel C. Transcriptional regulation of the human polymeric immunoglobulin receptor gene by interferon-γ. Mol Immunol 1997; 34:75-91.
19. Blanch V, Piskurich J, Kaetzel C. Cutting edge. Coordinate regulation of IFN regulatory factor-1 and the polymeric Ig receptor by proinflammatory cytokines. J Immunol 1999; 162:1232-5.
20. Johansen F-E, Bosloven B, Krajci P, Brandtzaeg P. A composite DNA element in the promoter of the polymeric immunoglobulin receptor regulates its constitutive expression. Eur J Immunol 1998; 28:1161-71.
21. Solorzano-Vargas, Sergio R, Wang J et al. Multiple transcription factors in 5′-flanking region of human polymeric Ig receptor control its basal expression. Am J Physiol 2002; 283:G415-G25.
22. Hempen P, Phillips K, Conway P, Sandoval K, Schneeman T, Wu H-J, Kaetzel C. Transcriptional regulation of the human polymeric Ig receptor gene: Analysis of basal promoter elements. J Immunol 2002; 169:1912-21.
23. Schjerven H, Brandtzaeg P, Johansen FE. A novel NF-kappa B/Rel site in intron 1 cooperates with proximal promoter elements to mediate TNF-alpha-induced transcription of the human polymeric Ig receptor. J Immunol 2001; 167 (11):6412-20.
24. Schjerven H, Brandtzaeg P, Finn-Erik J. Mechanism of IL-4-mediated up-regulation of the polymeric Ig receptor: Role of STAT6 in cell type-specific delayed transcriptional response. J Immunol 2000; 165:3898-906.
25. Kirchhoff S, Wilhelm D, Angel P, Hauser H. NFκB activation is required for interferon regulatory factor-1-mediated interferon β induction. Eur J Biochem 1999; 261:546-54.
26. Messner B, Stutz A, Albrecht B, Peiritsch S, Woisetschlager M. Cooperation of binding sites for STAT6 and NFκB/rel in the IL-4-induced up-regulation of the human IgE germline promoter. J Immunol 1997; 159:3330-7.
27. Augeron C, Laboisse CL. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 1984; 44 (9): 3961-9.
28. Piette J, Piret B, Bonizzi G, Schoonbroodt S, Merville M-P, Legrand-Poels S, Bours V. Multiple redox regulation in NF-κB transcription factor activation. J Biol Chem 1997; 378 (11):1237-45.
29. Natarajan K, Singh S, Burke T, Grunberger D, Aggarwal B. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc Natl Acad Sci U S A 1996; 93:9090-4.
30. Pierce J, Schoenleber R, Jesmok G, Best J, Moore S, Collins T, Gerritsen M. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 1997; 272: 21096-103.
31. Lee D, Goldberg A. Selective inhibitors of the proteosome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae. J Biol Chem 1996; 271:27280-4.
32. de-Mello M, Flodstrom M, Eizirik D. Ebselen and cytokine-induced nitric oxide synthase expression in insulin-producing cells. Biochem Pharmacol 1996; 52:1703-9.
33. Iimuro Y, Nishiura T, Hellerbrand C, Behrns K, Schoonhoven R, Grisham J, Brenner D. NFκB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 1998; 101:802-11.
34. Verrijdt G, Swinnen J, Peeters B, Verhoeven G, Rombauts W, Claessens F. Characterization of the human secretory component gene promoter. Biochim Biophys Acta 1997; 1350:147-54.
35. Kim I, Stadtman T. Inhibition of NF-κB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment. Proc Natl Acad Sci U S A 1997; 94:12904-7.
36. Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci U S A 1992; 89 (15):6901-5.
37. Mestecky J, Killian M, Immunoglobulin A (IgA). Methods Enzymol 1985; 116:37-75.
38. Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM. Mucosal immunity: implications for vaccine development. Immunobiology 1992; 184:157-79.
39. Corthesy B, Spertini F. Secretory immunoglobulin A. from mucosal protection to vaccine development. J Biol Chem 1999; 380: 1251-62.
40. Finn-Eirik J, Pekna M, Norderhaug I, Haneberg B, Hietala M, Krajci P, Betsholtz C, Brandtzaeg P. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin/secretory component-deficient mice. J Exp Med 1999; 190:915-21.